Lina M. Lauffer - Concepedia

Author

Lina M. Lauffer

University of Toronto

Also Known As

Lauffer, Lina, Lina Lauffer, Lina M. Lauffer

Publications

795

Citations

H-Index

Concepts

All Affiliations

University of Toronto Ludwig-Maximilians-Universität München Klinikum rechts der Isar Technical University of Munich LMU Klinikum

About

Lina M. Lauffer is an author at University of Toronto specializing in medicine, cancer research, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	191
2	Endocrinology	2	2	122
3	Health Sciences	1	1	47
4	Biochemistry	1	1	47
5	Diabetes	1	1	47

Lina M. Lauffer

Publications

784

Citations

H-Index

Page 1

	Year	Citations
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell Lina M. Lauffer, Roman Iakoubov, Patricia L. Brubaker Diabetes	2009	375
Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell Andrew J. Mulherin, Amy Oh, Helena Kim, Endocrinology	2011	155
Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice Roman Iakoubov, Lina M. Lauffer, Shivangi Trivedi, Endocrinology ImmunologyGastroenterologyCell DeathPathologyCarcinogenic Effects	2009	75
Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 Secretagogue Ganesh V. Sangle, Lina M. Lauffer, Anthony J. Grieco, Endocrinology Dipeptidylpeptidase-iv InhibitorInsulin SignalingProtein Kinase InhibitorGastrointestinal Peptide HormoneMetabolic Syndrome	2011	47
Essential Role for Protein Kinase Cζ in Oleic Acid-Induced Glucagon-Like Peptide-1 Secretion in Vivo in the Rat Roman Iakoubov, Ausma Ahmed, Lina M. Lauffer, Endocrinology	2011	47
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase‐2 inhibitor Stephan Lang, Lina M. Lauffer, Christoph Clausen, The FASEB Journal Chemoprevention StrategyImmunologyBiological MicroenvironmentsPathologyCancer Patients	2002	43
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition Stephan Lang, Sanjay Tiwari, Michaela Andratschke, Cancer Immunology Immunotherapy Neoadjuvant TherapyImmunologyImmune RestorationImmunoeditingImmunotherapy	2007	26
Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by <sup>18</sup>F <scp>DOPA</scp>‐<scp>PET</scp>/<scp>CT</scp> scanning Peter Kühnen, Ritana Matthae, Ved Bhushan Arya, Clinical Endocrinology	2014	16

Page 1